![Peter Schmidt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Peter Schmidt is currently the Chief Operating Officer at Qbiotics Group Ltd., a position started in 2012.
Formerly, Dr. Schmidt was Director-CMC & Preclinical Drug Development at Xenome Ltd.
Postes actifs de Peter Schmidt
| Sociétés | Poste | Début |
|---|---|---|
Qbiotics Group Ltd.
 Qbiotics Group Ltd. BiotechnologyHealth Technology Develops novel cell-signaling small molecules derived from natural sources for medical use | Directeur des opérations | 01/10/2012 |
Anciens postes connus de Peter Schmidt
| Sociétés | Poste | Fin |
|---|---|---|
Xenome Ltd.
 Xenome Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops peptide pharmaceuticals | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Xenome Ltd.
Xenome Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops peptide pharmaceuticals | Health Technology |
Qbiotics Group Ltd.
Qbiotics Group Ltd. BiotechnologyHealth Technology Develops novel cell-signaling small molecules derived from natural sources for medical use | Health Technology |
